Many breast cancer patients will get a financial boost, with key drug Truqap now listed on the PBS. Used for locally advanced or metastatic breast cancer, it will now cost just $31 per prescription, saving patients thousands annually.
Breakdown
- Trucap, an anti-cancer drug, improves quality of life for metastatic breast cancer patients. 18s
- Trucap blocks the AKT protein, reducing cancer growth and spread. 32s
- The drug previously cost patients up to $100,000 per course. 55s
- Trucap will be listed on the PBS, reducing patient costs to $31 per month and $25 from January. 1m 7s
- Around 3,000 women and some men are expected to benefit from the new listing each year. 1m 30s